A fatty acid ester that is the carboxylic ester obtained by the formal condensation of a fatty acid with methanol.
ChEBI ID: 4986
| Member | Definition | Role |
|---|---|---|
| 5-[10-(5-methoxy-1,5-dioxopentyl)-1,7-dioxa-4,10-diazacyclododec-4-yl]-5-oxopentanoic acid methyl ester | 5-[10-(5-methoxy-1,5-dioxopentyl)-1,7-dioxa-4,10-diazacyclododec-4-yl]-5-oxopentanoic acid methyl ester | |
| dimethyl succinate | Dimethyl succinate | |
| dimethyladipate | Dimethyl adipate | |
| lauric acid methyl ester | A fatty acid methyl ester of lauric acid. | methyl laurate |
| methyl caproate | A fatty acid methyl ester derived from hexanoic (caproic acid). | methyl hexanoate |
| methyl farnesoate | A member of the juvenile hormone family of compounds that is the methyl ester of farnesoic acid. Found in several species of crustaceans. | methyl farnesoate |
| methyl linoleate | A fatty acid methyl ester of linoleic acid. It has been isolated from Neolitsea daibuensis. | methyl linoleate |
| methyl linolenate | A fatty acid methyl ester derived from alpha-linolenic acid. | methyl linolenate |
| methyl octanoate | A fatty acid methyl ester resulting from the formal condensation of the carboxy group of octanoic acid with the hydroxy group of methanol. | methyl octanoate |
| methyl oleate | A fatty acid methyl ester resulting from the formal condensation of the carboxy group of oleic acid with methanol. | methyl oleate |
| methyl palmitate | Methyl palmitate | |
| methyl palmitoleate | A fatty acid methyl ester obtained from the formal condensation of methanol and palmitoleic acid. | methyl palmitoleate |
| methyl tetradecanoate | A fatty acid methyl ester resulting from the formal condensation of the carboxy group of tetradecanoic acid (myristic acid) with methanol. | methyl tetradecanoate |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 80 (12.90) | 18.7374 |
| 1990's | 120 (19.35) | 18.2507 |
| 2000's | 202 (32.58) | 29.6817 |
| 2010's | 175 (28.23) | 24.3611 |
| 2020's | 43 (6.94) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (0.14%) | 5.53% |
| Reviews | 15 (2.12%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 693 (97.74%) | 84.16% |